HIBT Lab! Immunai: Noam Solomon

HIBT Lab! Immunai: Noam Solomon

According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop a new drug is over $1 billion; and testing can take over 10 years.


Noam Solomon is on a mission to change this. His company, Immunai, is using artificial intelligence to create an atlas of the human immune system.


This week on How I Built This Lab, Guy talks with Noam about how Immunai’s immune system mapping is accelerating the development of new personalized drug therapies. Plus, Noam shares how Immunai’s culture of ‘not knowing’ drives scientific innovation.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episoder(804)

Shooting for the moon with Steve Altemus of Intuitive Machines

Shooting for the moon with Steve Altemus of Intuitive Machines

Our modern way of life requires more resources than ever before — resources that are becoming increasingly scarce and environmentally taxing to extract. Intuitive Machines co-founder and CEO Steve Alt...

21 Des 202337min

reCAPTCHA and Duolingo: Luis von Ahn (2020)

reCAPTCHA and Duolingo: Luis von Ahn (2020)

In 2000, Luis von Ahn was starting his PhD in computer science when he attended a talk and happened to learn about one of Yahoo's biggest problems: automated bots were signing up for millions of free ...

18 Des 20231h 7min

Framing the future of eyecare with Neil Blumenthal and Dave Gilboa of Warby Parker

Framing the future of eyecare with Neil Blumenthal and Dave Gilboa of Warby Parker

Warby Parker co-CEOs Neil Blumenthal and Dave Gilboa broke their scrappy startup into the eyewear industry in 2010—putting legacy manufacturers on notice by offering stylish glasses at much lower pric...

14 Des 202339min

Wondery: Hernan Lopez

Wondery: Hernan Lopez

When Hernan Lopez founded Wondery in 2016, podcasts were just starting to go mainstream. Five years later, his team had scored a number of hit shows and sold to Amazon for a reported $300 million. Not...

11 Des 20231h 16min

Full body preventive health care with Andrew Lacy of Prenuvo

Full body preventive health care with Andrew Lacy of Prenuvo

Andrew Lacy is the co-founder and CEO of Prenuvo, a company offering full body scans that have the potential to detect disease early and before symptoms. When Andrew was introduced to radiologist Rajp...

7 Des 202340min

Briogeo Hair Care: Nancy Twine (2020)

Briogeo Hair Care: Nancy Twine (2020)

In 2010, a tragic personal event changed the trajectory of Nancy Twine's life. Suddenly, her promising job at Goldman Sachs no longer seemed fulfilling; she wanted something more.Drawing inspiration f...

4 Des 20231h 13min

The surprise that's saving food with Lucie Basch of Too Good To Go (2023)

The surprise that's saving food with Lucie Basch of Too Good To Go (2023)

Collaboration is the new competition: that was French entrepreneur Lucie Basch’s philosophy when she approached a group of Danish founders who happened to be working on a similar food waste reduction ...

30 Nov 202341min

CAVA: Ted Xenohristos and Brett Schulman

CAVA: Ted Xenohristos and Brett Schulman

When Ted Xenohristos and two childhood friends opened their first sit-down Greek restaurant in 2006, they had no idea it would eventually grow into CAVA, a sprawling national chain that serves stuffed...

27 Nov 20231h 16min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
finansredaksjonen
pengesnakk
pengepodden-2
livet-pa-veien-med-jan-erik-larssen
utbytte
morgenkaffen-med-finansavisen
tid-er-penger-en-podcast-med-peter-warren
okonomiamatorene
lederpodden
lydartikler-fra-aftenposten
rss-markedspuls-2
rss-investering-gjort-enkelt
shifter
rss-impressions-2
rss-fa-makro